FEATURES

Neurolens Receives $45 Million in Growth Capital From Trinity Capital

PHOENIX—Trinity Capital Inc., a leading provider of diversified financial solutions to growth-stage companies, announced the commitment of $45 million in growth capital to Neurolens, a company commercializing innovative solutions to optimize vision.  Read more...


Outlook Therapeutics Announces Strategic Organizational Realignment

ISELIN, N.J.—Outlook Therapeutics, Inc., a biopharmaceutical company working to achieve U.S. Food and Drug Administration approval for the first ophthalmic formulation of bevacizumab for the treatment of retinal diseases, announced a realignment of resources.  Read more...


Johnson & Johnson MedTech Outlines Growth Strategies at Enterprise Business Review

NEW BRUNSWICK, N.J.—At a meeting with the investment community, members of Johnson & Johnson’s executive committee and leaders from the Innovative Medicine and MedTech businesses highlighted the company’s overarching strategy, its Innovative Medicine and MedTech pipelines and long-term financial outlook.  Read more...


MOST READ STORIES

CURRENT
ISSUE

November-December 2023

November-December 2023

FEATURED COURSE

20/20 Pro to Pro Continuing Education